Packaging Considerations for Biopreservation

The packaging system chosen for biopreservation is critical for many reasons. An ideal biopreservation container system must provide for closure integrity, sample stability and ready access to the preserved material. This means the system needs to be hermetically sealed to ensure integrity of the specimen is maintained throughout processing, storage and distribution; the system must remain stable over long periods of time as many biobanked samples may be stored indefinitely; and functionally closed access systems must be used to avoid contamination upon sample withdraw. This study reviews the suitability of a new commercially available vial configuration container utilizing blood bag style closure and access systems that can be hermetically sealed and remain stable through cryopreservation and biobanking procedures. This vial based systems allow for current good manufacturing/tissue practice (cGTP) requirements during processing of samples and may provide the benefit of ease of delivery by a care giver. In this study, the CellSeal® closed system cryovial was evaluated and compared to standard screw cap vials. The CellSeal system was evaluated for durability, closure integrity through transportation and maintenance of functional viability of a cryopreserved mesenchymal stem cell model. The results of this initial proof-of-concept study indicated that the CellSeal vials are highly suitable for biopreservation and biobanking, and provide a suitable container system for clinical and commercial cell therapy products frozen in small volumes.

[1]  M. Crump,et al.  Microbial contamination of harvested bone marrow and peripheral blood. , 1995, Bone marrow transplantation.

[2]  E. Woods,et al.  Collection, cryopreservation, and characterization of human dental pulp-derived mesenchymal stem cells for banking and clinical use. , 2008, Tissue engineering. Part C, Methods.

[3]  S. Jones,et al.  Transmission of virus particles by cryotherapy and multi‐use caustic pencils: a problem to dermatologists? , 1989, The British journal of dermatology.

[4]  R. Benjamin,et al.  Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components , 1997, Transfusion.

[5]  D. Stroncek,et al.  Adverse reactions in patients transfused with cryopreserved marrow , 1991, Transfusion.

[6]  Cheryl E. Kennedy,et al.  Acetic acid production and glass transition concerns with ethylene-vinyl acetate used in photovoltaic devices , 2007 .

[7]  D. Sumstad,et al.  Loss of integrity of umbilical cord blood unit freezing bags: description and consequences , 2008, Transfusion.

[8]  Goodman Jm Liquid nitrogen therapy of warts and other skin lesions. , 1960 .

[9]  R. M. Childs,et al.  Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences. , 2002, Cytotherapy.

[10]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[11]  S. Shi,et al.  Recovery of Stem Cells from Cryopreserved Periodontal Ligament , 2005, Journal of dental research.

[12]  D. Sire,et al.  Transmission of papovavirus by cryotherapy applicator. , 1971, JAMA.

[13]  M. Risbud,et al.  Biocompatibility assessment of polytetrafluoroethylene/wollastonite composites using endothelial cells and macrophages , 2001, Journal of biomaterials science. Polymer edition.

[14]  Sung Chul Kim,et al.  Chemical structure and physical properties of cyclic olefin copolymers (IUPAC Technical Report) , 2005 .

[15]  Erik J Woods,et al.  Clinical grade adult stem cell banking , 2009, Organogenesis.

[16]  J. Ritz,et al.  Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering , 1996, Transfusion.

[17]  S. Gronthos,et al.  Comparison of human dental pulp and bone marrow stromal stem cells by cDNA microarray analysis. , 2001, Bone.

[18]  Michael J Akers,et al.  Top ten hot topics in parenteral science and technology. , 2007, PDA journal of pharmaceutical science and technology.

[19]  J. M. Goodman Liquid nitrogen therapy of warts and other skin lesions. , 1960, Canadian Medical Association journal.

[20]  Y. Sakai,et al.  Soluble Factor–DependentIn VitroGrowth and Maturation of Rat Fetal Liver Cells in a Three-Dimensional Culture System , 2008 .

[21]  Aniruddha Bagchi,et al.  Container system for enabling commercial production of cryopreserved cell therapy products. , 2010, Regenerative medicine.

[22]  D. Kirouac,et al.  The systematic production of cells for cell therapies. , 2008, Cell stem cell.

[23]  J. Jansen,et al.  Multilineage differentiation potential of stem cells derived from human dental pulp after cryopreservation. , 2006, Tissue engineering.

[24]  H. Lazarus,et al.  Contamination during in vitro processing of bone marrow for transplantation: clinical significance. , 1991, Bone marrow transplantation.

[25]  A. Goldstone,et al.  Hepatitis B transmission from contaminated cryopreservation tank , 1995, The Lancet.

[26]  P. Came,et al.  Biohazard: virus-contaminated liquid nitrogen. , 1976, Science.

[27]  S. S. Qadry,et al.  Evaluation of CZ-resin vials for packaging protein-based parenteral formulations. , 2003, International journal of pharmaceutics.

[28]  R. Tedder,et al.  Hepatitis B nucleotide sequence analysis: linking an outbreak of acute hepatitis B to contamination of a cryopreservation tank. , 1996, Journal of virological methods.

[29]  E. Woods,et al.  Optimized cryopreservation method for human dental pulp-derived stem cells and their tissues of origin for banking and clinical use. , 2009, Cryobiology.

[30]  D E H Tee,et al.  Book Review: Culture of Animal Cells: A Manual of Basic Technique , 1984 .

[31]  S. Nannarone,et al.  Prevention of plasticizer leaching from PVC medical devices by using organic -inorganic hybrid coatings , 2004 .